Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Anthony M Treston"'
Autor:
Michael Callahan, Anthony M Treston, Grace Lin, Marla Smith, Brian Kaufman, Mansoora Khaliq, Lisa Evans DeWald, Kevin Spurgers, Kelly L Warfield, Preeya Lowe, Matthew Duchars, Aruna Sampath, Urban Ramstedt
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 16, Iss 8, p e0010636 (2022)
BackgroundUV-4 (N-(9'-methoxynonyl)-1-deoxynojirimycin, also called MON-DNJ) is an iminosugar small-molecule oral drug candidate with in vitro antiviral activity against diverse viruses including dengue, influenza, and filoviruses and demonstrated in
Externí odkaz:
https://doaj.org/article/1b9a38644e1447e182ac97752d59a1a1
Autor:
Sharanbasappa S. Karade, Evelyn J. Franco, Ana C. Rojas, Kaley C. Hanrahan, Alexander Kolesnikov, Wenbo Yu, Alexander D. MacKerell, Daniel C. Hill, David J. Weber, Ashley N. Brown, Anthony M. Treston, Roy A. Mariuzza
Publikováno v:
Journal of Medicinal Chemistry. 66:2744-2760
Publikováno v:
Biochemistry. 61(10)
All viruses depend on host cell proteins for replication. Denying viruses' access to the function of critical host proteins can result in antiviral activity against multiple virus families. In particular, small-molecule drug candidates which inhibit
Autor:
Sharanbasappa S. Karade, Michelle L. Hill, J. L. Kiappes, Rajkumar Manne, Balakishan Aakula, Nicole Zitzmann, Kelly L. Warfield, Anthony M. Treston, Roy A. Mariuzza
Publikováno v:
Journal of medicinal chemistry. 64(24)
Most enveloped viruses rely on the host cell endoplasmic reticulum (ER) quality control (QC) machinery for proper folding of glycoproteins. The key ER α-glucosidases (α-Glu) I and II of the ERQC machinery are attractive targets for developing broad
Autor:
Michael Callahan, Anthony M. Treston, Grace Lin, Marla Smith, Brian Kaufman, Mansoora Khaliq, Lisa Evans DeWald, Kevin Spurgers, Kelly L. Warfield, Preeya Lowe, Matthew Duchars, Aruna Sampath, Urban Ramstedt
Publikováno v:
PLoS neglected tropical diseases. 16(8)
Background UV-4 (N-(9’-methoxynonyl)-1-deoxynojirimycin, also called MON-DNJ) is an iminosugar small-molecule oral drug candidate with in vitro antiviral activity against diverse viruses including dengue, influenza, and filoviruses and demonstrated
Autor:
J. L. Kiappes, Alessandro T. Caputo, Raymond A. Dwek, Pietro Roversi, Nicholas Sheets, Kelly L. Warfield, Anthony M. Treston, Matthew Duchars, Nicole Zitzmann, Johan C. Hill, Dale L. Barnard, Dominic S. Alonzi, Sujan Shresta, Julia E. Biggins
Publikováno v:
Journal of medicinal chemistry. 63(8)
Influenza and dengue viruses present a growing global threat to public health. Both viruses depend on the host endoplasmic reticulum (ER) glycoprotein folding pathway. In 2014, Sadat et al. reported two siblings with a rare genetic defect in ER α-gl
Autor:
Thomas W. Geisbert, Travis K. Warren, Brennan Klose, Michael V. Callahan, Kelly S. Stuthman, Xiangguo Qiu, Kelly L. Warfield, Sean A. Van Tongeren, Joan B. Geisbert, Anthony M. Treston, Urban Ramstedt, Gary Wong, Chad E. Mire, Krystle N. Agans, Nicole L. Garza, Amy C. Shurtleff, Jay Wells
Publikováno v:
Antiviral Research. 138:22-31
Iminosugars are host-directed antivirals with broad-spectrum activity. The iminosugar, N-butyl-deoxynojirimycin (NB-DNJ or Miglustat®), is used in humans for treatment of Gaucher's disease and has mild antiviral properties. More potent analogs of NB
Autor:
Herbert P. Schweizer, Kelly L. Warfield, Sunisa Chirakul, Jeffry D Shearer, Michelle L Saylor, Henry S. Heine, George L. Drusano, Steven D. Zumbrun, Anthony M. Treston, Christine M Butler, Arnold Louie
Publikováno v:
Antimicrobial Agents and Chemotherapy
Burkholderia pseudomallei, the etiological agent of melioidosis, is a Gram-negative bacterium with additional concern as a biothreat pathogen. The mortality rate from B. pseudomallei varies depending on the type of infection and extent of available h
Autor:
Jamie Arnott, Jens C. Eickhoff, Michael A. Carducci, Anthony M. Treston, Justine Yang Bruce, George Wilding, Roberto Pili, Glenn Liu, Theodore F. Logan
Publikováno v:
Investigational New Drugs. 30:794-802
Background Current treatment for metastatic renal cell cancer with vascular endothelial growth factor (VEGF) tyrosine kinase inhibitors (TKI) have provided improved overall survival, but complete responses are rare. We conducted a multicenter phase I
Autor:
Anthony M. Treston, Gregory E. Agoston, LiQuan Wang, Gaetan Ladouceur, Zhenglai Fang, Mark Cushman
Publikováno v:
Tetrahedron. 65:10535-10543
ENMD-1198 is a biologically active analogue of the antitumor drug 2-methoxyestradiol. Four human metabolites of ENMD-1198 were identified through synthesis and liquid chromatography/mass spectrometry comparisons of the metabolites with the synthetic